# Steroid Treatment for Sickle Cell Pain Crisis

> **NCT00263562** · PHASE3 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 18 (actual)

## Conditions studied

- Sickle Cell Disease
- Vaso-occlusive Crisis

## Interventions

- **DRUG:** Steroid arm
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00263562
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12-01
- **Primary completion:** 2008-06-13
- **Final completion:** 2008-06-13
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** poor enrollment, availability of more effective medications
- **Last updated:** 2020-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263562, "Steroid Treatment for Sickle Cell Pain Crisis". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00263562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*